These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 63805)

  • 21. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 22. Terminal deoxynucleotidyl transferase activity in lymphoma.
    Habeshaw JA; Catley PF; Stansfield AG; Ganeshaguru K; Hoffbrand AV
    Br J Cancer; 1979 May; 39(5):566-9. PubMed ID: 314814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant lymphomas as tumours of the immune system.
    Berard CW; Cossman J; Jaffe ES
    Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte markers in non-Hodgkin's lymphomas.
    Payne SV; Smith JL; Jones DB; Wright DH
    Br J Cancer; 1977 Jul; 36(1):57-64. PubMed ID: 329850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Categorization of non-Hodgkin's hematosarcomas (lymphomas) according to T- and B-cell markers: its value for diagnosis and prognosis.
    Belpomme D; Caillou B; Lelarge N; Botto I; Pujade Lauraine E; Denaro L; Gerard-Marchant R; Davies AJ; Mathé G
    Recent Results Cancer Res; 1978; 64():146-57. PubMed ID: 366693
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
    Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
    Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
    [No Abstract]   [Full Text] [Related]  

  • 30. B and T cell lymphomas. Analysis of blood and lymph nodes in 87 patients.
    Gajl-Peczalska KJ; Bloomfield CD; Coccia PF; Sosin H; Brunning RD; Kersey JH
    Am J Med; 1975 Nov; 59(5):674-85. PubMed ID: 1106193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
    Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
    Noguchi S; Bukowski R; Deodhar S; Hewlett JS
    Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.
    Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY
    Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
    Byrne GE
    Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant lymphomas in Korea.
    Chi JG; Shin SS; Ahn GH; Lee SK
    Jpn J Clin Oncol; 1985 Dec; 15(4):653-9. PubMed ID: 4094098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia.
    Su IJ; Shih LY; Kadin ME; Dun P; Hsu SM
    Am J Clin Pathol; 1985 Dec; 84(6):715-23. PubMed ID: 3000162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiinstitution study of non-Hodgkin's lymphomas using frozen section immunoperoxidase: the Southeastern Cancer Study Group experience.
    Borowitz MJ; Newby S; Brynes RK; Cousar JB; Whitcomb CC; Crissman JD; Byrne GE; Collins RD
    Blood; 1984 May; 63(5):1147-52. PubMed ID: 6370333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue immunomicroscopic evaluation of monoclonality of B-cell lymphomas: comparison with cell suspension studies.
    Tubbs RR; Sheibani K; Weiss RA; Sebek BA; Deodhar SD
    Am J Clin Pathol; 1981 Jul; 76(1):24-8. PubMed ID: 6789669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.